, Tracking Stock Market Picks
Enter Symbol:
Corcept Therapeutics Incorporated (CORT) [hlAlert]

down 33.53 %

Corcept Therapeutics Incorporated (CORT) rated Sell by BioLogic Equity Research

Posted on: Thursday,  Jan 5, 2012  8:25 AM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell Corcept Therapeutics Incorporated (NASDAQ: CORT) on 01/05/2012, when the stock price was $3.37.
Since then, Corcept Therapeutics Incorporated has gained 50.45% as of 01/15/2016's recent price of $5.07.
If you would have followed this BioLogic Equity Research's recommendation on CORT, you would have lost 33.53% of your investment in 1471 days.

Corcept Therapeutics Incorporated (Corcept) is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases. The Company focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Corcept's principal product candidate, CORLUX, modulates the effect of cortisol by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor, also known as the Type II or GR receptor.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/5/2012 8:25 AM Sell
as of 12/31/2012
1 Week up  5.92 %
1 Month up  0.69 %
3 Months up  48.74 %
1 YTD up  57.56 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy